凝微球-酸水凝组合系统,用于持续和胃向的5 - 甲的输送
相关实验视频
Updated: Aug 1, 2026

10:33
Generation of Alginate Microspheres for Biomedical Applications
Published on: August 12, 2012
20.8K
Didem Aycan1, İnanç Gül1, Valeria Yorulmaz1
1Marmara University, Department of Chemical Engineering, Istanbul, Turkey.
International journal of biological macromolecules
|November 16, 2023
概括
开发了一种新的胃向药物递送系统,使用凝微球和甲基烯酸酸盐水凝,用于5-甲 (5-FU). 该系统提供受控释放,增强胃癌的抗癌疗法疗效.
科学领域:
- 生物材料科学 生物材料科学
- 药物输送系统 药物输送系统
- 在瘤学瘤学.
背景情况:
- 胃癌的治疗需要有效的药物输送到瘤部位.
- 常规化疗往往导致全身副作用.
- 需要新的药物输送系统来改善治疗结果.
研究的目的:
- 开发一种新的凝微球/甲基烯酸酸水凝组合系统 (5-FU-GELms/Alg-MA) 用于胃向输送5-甲 (5-FU).
- 在模拟的胃条件下评估开发系统的药物释放特征和机制.
主要方法:
- 用5FU装载的凝微球 (5-FU-GELms) 用油中的水乳化方法制备.
- 甲基化酸盐 (Alg-MA) 是通过甲基化合成的.
- 5-FU-GELms/Alg-MA水凝系统是通过UV交叉连接制造的,并在pH 1.2下对胀和体外药物释放进行了评估.
主要成果:
- 与单独的微球相比,5-FU-GELms/Alg-MA水凝系统表现出更受控和持续的5-FU释放.
- 水凝矩阵充当了屏障,减少了早期的累积药物释放.
- 药物释放动力学跟随Fickian扩散,表明扩散控制的释放.
结论:
- 开发的5-FU-GELms/Alg-MA水凝综合系统显示出作为胃向药物载体的潜力.
- 这种系统可以提高治疗效果,减少胃癌治疗中的全身副作用.
- 需要进一步的研究来探索其临床适用性.
相关概念视频
Routes of Drug Administration: Enteral
Medications can be administered through the enteral route using liquids, capsules, or tablets.
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...
Drug Elimination by Renal Route: Tubular Secretion
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Mucosal Barrier of the Stomach
The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
Gram-negative Bacterial Protein Secretion Systems
Gram-negative bacteria utilize sophisticated protein secretion systems to transport proteins across their double-membrane envelope into the extracellular environment or host cells. Based on their mechanism of action, these systems are classified into one-step and two-step pathways.One-Step Secretion Systems (Types I, III, IV, and VI)One-step secretion systems bypass the periplasm entirely, forming a continuous channel that spans both the inner and outer membranes:Type I Secretion System (T1SS):...

